AGT and chronic kidney disease: A significant decrease in MSNA was observed in CKD patients who received treatment with an oral ARB.25, 26, 27 Thus, the effects of olmesartan on sympathetic nerve activity may be mediated through inhibition of Ang II in the brain and suppression of renal afferent nerve activity due to improvement of renal ischemia.